D-0156-2021 Class II Terminated

Recalled by Taro Pharmaceuticals U.S.A., Inc. — Hawthorne, NY

FDA drug recall D-0156-2021 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Nov 17, 2020 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%. The recall status is terminated (terminated Feb 21, 2024). Affected quantity: 34,920 0.5 oz tubes.

Recall details

Product Type
Drugs
Report Date
Dec 23, 2020
Initiation Date
Nov 17, 2020
Termination Date
Feb 21, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
34,920 0.5 oz tubes

Product description

RiteAid Pharmacy RIngworm Cream, Clotrimazole Cream USP, 1%, Antifungal NET W 0.5 oz. (14.2g), Distributed by: Rite Aid, 30 Hunter Lane, Camp Hill, PA 17011 Made in Canada. UPC 0 11822 53812 1

Reason for recall

Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.

Distribution pattern

Distributed Nationwide in the USA and Canada

Code information

Lot#: A873630559, Exp Dec 2020.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0156-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0156-2021. Report a data issue: hello@regdatalab.com.